Related Experiment Video
Updated: Jun 3, 2025

10:36
Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
10.4K
Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer
Maciej Skrzypczak1, Ewa Wolinska2, Łukasz Adaszek3
1Chair and Department of Gynecology, Medical University of Lublin, 20-954 Lublin, Poland.
International Journal of Molecular Sciences
|January 11, 2025
Summary
Epigenetic mechanisms regulate estrogen signaling, impacting ovarian cancer development and progression. Targeting these epigenetic changes offers potential new treatments for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Ovarian cancer is a leading cause of cancer deaths in women.
- Estrogen signaling pathways, mediated by estrogen receptors (ERα, ERβ, GPER1), play a crucial role in ovarian cancer pathogenesis, progression, and metastasis.
- Epigenetic mechanisms, including histone modifications and DNA methylation, regulate the expression and activity of estrogen receptors and their coregulators.
Purpose of the Study:
- To summarize and update the current understanding of epigenetic mechanisms that regulate estrogen signaling in ovarian cancer.
- To review the role of these epigenetic mechanisms in ovarian cancer development, progression, and metastasis.
- To assess the potential of epigenetic drugs for ovarian cancer treatment.
Main Methods:
- Literature review of publications on epigenetic regulation of estrogen signaling in ovarian cancer.
- Publications were sourced from the PubMed database.
- Analysis of existing research to synthesize current knowledge and identify therapeutic opportunities.
Main Results:
- Estrogen signaling is intricately linked to ovarian cancer through genetic and epigenetic alterations.
- Epigenetic modifications directly influence the expression and function of estrogen receptors and associated proteins.
- The interplay between epigenetics and estrogen signaling is a key driver of ovarian cancer progression.
Conclusions:
- Epigenetic regulation of estrogen signaling is a critical factor in ovarian cancer.
- Understanding these epigenetic mechanisms provides insights into ovarian cancer pathogenesis.
- Epigenetic therapies represent a promising avenue for novel ovarian cancer treatment strategies.
Related Concept Videos
Internal Receptors
69.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.4K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Hormonal Regulation of the Menstrual Cycle
283
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
283
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K

